The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies

R Bai, Y Li, L Jian, Y Yang, L Zhao, M Wei - Molecular cancer, 2022 - Springer
Given that hypoxia is a persistent physiological feature of many different solid tumors and a
key driver for cancer malignancy, it is thought to be a major target in cancer treatment …

Targeting hypoxia-inducible factors: therapeutic opportunities and challenges

X Yuan, W Ruan, B Bobrow, P Carmeliet… - Nature Reviews Drug …, 2024 - nature.com
Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that are crucial for
adaptation of metazoans to limited oxygen availability. Recently, HIF activation and …

Tumor hypoxia: From basic knowledge to therapeutic implications

C Liao, X Liu, C Zhang, Q Zhang - Seminars in cancer biology, 2023 - Elsevier
Diminished oxygen availability, termed hypoxia, within solid tumors is one of the most
common characteristics of cancer. Hypoxia shapes the landscape of the tumor …

Targeting intratumoral hypoxia to enhance anti-tumor immunity

GL Semenza - Seminars in Cancer Biology, 2023 - Elsevier
Cancers express a large battery of genes by which they establish an immunosuppressive
tumor microenvironment. Many of these genes are induced by intratumoral hypoxia through …

[HTML][HTML] Regulation of the HIF switch in human endothelial and cancer cells

J Slawski, M Jaśkiewicz, A Barton, S Kozioł… - European Journal of …, 2024 - Elsevier
Hypoxia-inducible factors (HIFs) are transcription factors that reprogram the transcriptome
for cells to survive hypoxic insults and oxidative stress. They are important during embryonic …

[HTML][HTML] HIF-1α inhibition improves anti-tumor immunity and promotes the efficacy of stereotactic ablative radiotherapy (SABR)

CW Song, H Kim, H Cho, MS Kim, SH Paek, HJ Park… - Cancers, 2022 - mdpi.com
Simple Summary Stereotactic ablative radiotherapy (SABR), which irradiates tumors with
high-dose radiation per fraction, promotes anti-tumor immunity by stimulating various …

Progress in the discovery and development of anticancer agents from marine cyanobacteria

H Luesch, EK Ellis, QY Chen, R Ratnayake - Natural Product Reports, 2025 - pubs.rsc.org
Covering 2010–April 2024 There have been tremendous new discoveries and
developments since 2010 in anticancer research based on marine cyanobacteria. Marine …

Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment

X Guo, R Sui, H Piao - CNS Neuroscience & Therapeutics, 2023 - Wiley Online Library
Gliomas are the most common primary malignant tumors in the central nervous system.
However, conventional treatments, such as surgical resection and postoperative combined …

HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications

N Taneja, A Chauhan, R Kulshreshtha, S Singh - Life Sciences, 2024 - Elsevier
Cancer cells undergo metabolic reprogramming to survive in hypoxic conditions and meet
the elevated energy demands of the cancer microenvironment. This metabolic alteration is …

Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1

YN Guillen-Quispe, SJ Kim, S Saeidi, T Zhou… - Free Radical Biology …, 2023 - Elsevier
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) isomerizes the nearby proline
(Pro) residue when it detects phosphorylated serine (Ser) or threonine (Thr) of target …